Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ksleedr | Other Identifier | Samsung Medical Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to compare the efficacy between Electromagnetic Stimulation therapy and Electromagnetic Stimulation therapy with Extracorporeal Biofeedback in Stress Urinary Incontinence patient.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Electromagnetic stimulation therapy | Experimental | Electromagnetic stimulation therapy group |
|
| Electromagnetic stimulation therapy with biofeedback | Experimental | Electromagnetic stimulation therapy with biofeedback group |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Electromagnetic stimulation therapy (BIOCON-2000) | Device |
| ||
| Electromagnetic stimulation therapy with biofeedback |
| Measure | Description | Time Frame |
|---|---|---|
| Rate comparison of complete recovery in stress pad test after 12 weeks of treatment | Complete recovery is defined as urinary leakage below than 2 gram in stress pad test. | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Incontinence Severity VAS at baseline,4weeks,8weeks,12weeks after treatment | 12 weeks | |
| Sandvik questionnaire at baseline,4weeks,8weeks,12weeks after treatment | 12 weeks | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kyu-Sung Lee, Ph.D | Samsung Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Samsung Medical Center | Seoul | 135-710 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Device |
|
| Incontinence - Quality of Life questionnaire at baseline,8weeks,12 weeks after treatment |
| 12 weeks |
| Benefit,Satisfaction and Willingness to Continue questionnaire at 12 weeks after treatment | 12 weeks |
| Pelvic floor muscular strength at baseline,4weeks,8weeks,12weeks after treatment | Intravaginal pressure, Extracorporeal pelvic floor muscular strength, Oxford Scale at baseline,4weeks,8weeks,12weeks after treatment | 12 weeks |
| ID | Term |
|---|---|
| D014550 | Urinary Incontinence, Stress |
| ID | Term |
|---|---|
| D014549 | Urinary Incontinence |
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D001676 | Biofeedback, Psychology |
| ID | Term |
|---|---|
| D026441 | Mind-Body Therapies |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
| D030141 | Feedback, Psychological |
Not provided
Not provided